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   SPECTROPHOTOMETRIC DETERMINATION 
OF TADALAFIL IN PURE AND DOSAGE 
FORMS 
Two simple, rapid, and extractive spectrophotometric methods were developed 
for the determination of tadalafil (TDF) in both pure and tablet dosage form. 
These methods are based on the formation of ion-pair complexes between the 
basic nitrogen of the drug with bromocresol purple (BCP) and methyl orange 
(MO) in acidic buffer solution. The formed complexes were extracted with chlo-
roform and measured at 410 and 425 nm using BCP and MO, respectively. 
Beer’s law was obeyed in the range 2.0–20 µg mL
−1 with correlation coefficient 
(n = 6) ≥0.9996. The molar absorptivity, Sandell sensitivity, detection and quan-
tification limits were also calculated. The composition of the ion pairs was found 
1:1 by Job’s method. The proposed methods have been applied successfully 
for the analysis of TDF in pure and in its dosage forms. These developed me-
thods were validated for accuracy and precision. 
Key words: tadalafil; spectrophotometry; ion pair complex; bromocresol purple; 
methyl orange. 
 
 
Tadalafil (TDF) is a selective inhibitor of cyclic 
guanosine monophosphate (cGMP)-specific phospho-
diesterase type 5 (PDE5), used in the management of 
erectile dysfunction. Chemically tadalafil is pyrazino-
[1’,2’:1,6]pyrido[3,4-b]indole-1,4-dione, 6-(1,3-benzodi-
oxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR) 
(Figure 1). It is not official in any of the pharmaco-
poeias. It is listed in the Merck Index [1] and Mar-
tindale, The Complete Drug Reference [2]. 
 
Figure 1. The chemical structure of tadalafil. 
Extensive literature survey revealed that the 
determination of TDF in pure and dosage forms are 
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not official in any pharmacopoeia and therefore, re-
quire much more investigation. Several analytical me-
thods that have been reported for the estimation of 
TDF in biological fluids or pharmaceutical dosage forms 
include liquid chromatography [3-7], densitometry [8] 
and spectrophotometry [9-11]. 
The well-established spectrophotometric method 
employs ion-pair extraction. In this case, an ion-pair is 
formed between basic compounds and an anionic dye 
such as bromocresol purple (BCP) and methyl orange 
(MO). At a specific pH, the ion-pair is extracted into 
an organic solvent, which is immiscible with water, 
and the concentration of the resulting ion pair in the 
organic phase is determined spectrophotometrically 
[12-20].  
In the present investigation, we report the deve-
lopment of accurate, reproducible, less time consum-
ing and adequately sensitive validated extractive spec-
trophotometric methods based on the formation of 
ion-pair complexes between TDF with bromocresol 
purple (BCP) and methyl orange (MO), compared with 
other reported methods. The proposed methods were 
applied to the determination of TDF in tablets dosage 
form. No interference was observed in the assay of 
TDF from common excipients in levels found in do-
sage form. These methods are validated by statistical 
data and can be adopted by the pharmaceutical labo-
ratories for industrial quality control. A. AL KAF, A.A. GOUDA: SPECTROPHOTOMETRIC DETERMINATION OF TADALAFIL…  CI&CEQ 17 (2) 125−132 (2011) 
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EXPERIMENTAL 
Apparatus 
All absorption spectra were made using an Op-
tima UV-VIS spectrometer (SP-3000 plus) (Tokyo, 
Japan), equipped with 10 mm matched quartz cells. A 
Hanna pH-meter instrument (pH 211) (Romania) was 
used for checking the pH of Buffer solutions. 
Materials and reagents 
All chemicals and reagents were of analytical 
grade and water was always bidistilled water.  
Material 
Tadalafil (TDF) was kindly supplied by Biophar-
maceutical Industries Company (BioPharm), Sana’a, 
Yemen. 
Pharmaceutical formulations 
Salil tablets (Biopharm, Sana’a, Yemen), la-
beled to contain 10 mg TDF per tablet.  
Standard solution 
A stock standard solution (100 µg mL
–1) of TDF 
was prepared by dissolving 10 mg of pure TDF in 100 
mL of methanol and further diluted with the same sol-
vent as appropriate. 
Reagents 
Bromocresol purple (BCP) and methyl orange 
(MO)  (BDH Chemicals LTD, Poole, England) were 
used without further purification. 
A stock solution of 0.1 % (w/v) and (1.0×10
−3 M) 
was prepared by dissolving the appropriate weight of 
bromocresol purple (BCP) and methyl orange (MO) in 
10 mL of methanol and diluted to 100 mL with bidis-
tilled water. 
These solutions are stable for at least 1 week if 
kept in the refrigerator. 
Series of buffer solutions of KCl–HCl (pH 1.5- 
–4.2), NaOAc–HCl (pH 1.99-4.92), NaOAc–AcOH (pH 
2.8-6.0) and potassium hydrogen phthalate–HCl (pH 
2.0-6.0) were prepared by following the standard me-
thods [21]. Freshly prepared solutions were always 
employed. 
Construction of calibration curves 
Aliquots of TDF ranging from 0.2–2.0 mL of stan-
dard solution (100 µg mL
-1) were transferred into a se-
ries of separating funnels. To each separating funnel 
2.0 mL acetate buffer of pH 3.5 and 2.0 or 1.5 ml of 
0.1 % (w/v) (BCP and MO) reagent solutions, respec-
tively, were added and the volume of the aqueous 
layer was adjusted to 10 mL with distilled water. The 
mixture was extracted twice with 10 mL of chloroform 
by shaking for 2.0 min, then allowed to stand for clear 
separation of the two phases and the chloroform layer 
was passed through anhydrous sodium sulphate. The 
chloroform extracts were collected and diluted to 10 
mL with chloroform. The absorbances of the yellow 
colored complexes were measured at 410 and 425 
nm using BCP and MO, respectively against the rea-
gent blank similarly prepared. All measurements were 
made at room temperature (25±2 °C). The procedu-
res were repeated for other analyte aliquots and cali-
bration plots were drawn to calculate the amount of 
drug in unknown analyte samples. 
Procedures for tablets dosage form 
The contents of twenty tablets (Salil, 10 mg TDF 
per tablet) were crushed, powdered, weighed out and 
the average weight of one tablet was determined. An 
accurate weight equivalent to 10 mg TDF was trans-
ferred into a 100 mL volumetric flask containing 15 
mL of methanol and the flask was kept for ultrasoni-
cation for 5 min, then it was diluted up to the mark 
with methanol and the solution was filtered through 
Whatman filter paper No. 41. From the above solution 
5 mL was pipetted out into a 50 mL volumetric flask 
and the volume was made up to the mark with distil-
led water. The final concentration of TDF was brought 
to 100 μg mL
-1 and used for the analysis. 
RESULTS AND DISCUSSION 
Absorption spectra 
The nitrogenous drugs are present in positively 
charged protonated forms and acidic dyes present 
mainly in anionic form at pH ≥ 2.5. So when treated 
with an acid dye at pH range (2.8-6.0) of acetate buf-
fer, a yellow ion-pair complex which is extracted with 
chloroform is formed. The absorption spectra of the 
ion-pair complexes, which were formed between TDF 
and each of BCP and MO were measured in the ran-
ge 350–550 nm against the blank solution. The ion-
pair complexes show maximum absorbance at 410 
and 425 nm using BCP and MO methods, respecti-
vely. The optimum reaction conditions for determina-
tion of the ion-pair complexes were established. Then 
linearity, accuracy, precision, sensitivity and stability 
of proposed methods were described and these deve-
loped methods applied to pharmaceutical prepara-
tions and obtained results evaluated statistically. 
Optimum reaction conditions for complex formation 
The optimization of the methods was carefully 
studied to achieve complete reaction formation, high-
est sensitivity and maximum absorbance. Reaction 
conditions of the ion-pair complex were found by stu-A. AL KAF, A.A. GOUDA: SPECTROPHOTOMETRIC DETERMINATION OF TADALAFIL…  CI&CEQ 17 (2) 125−132 (2011) 
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dying with preliminary experiments such as pH of buf-
fer, type of organic solvent, volumes of the dye, and 
shaking time for the extraction of ion-pair complexes. 
Selecting of the extracting solvents 
The effect of several extracting organic solvents 
on the ion-pair complex was examined. Chloroform, 
carbon tetrachloride, ethyl acetate, diethylether, tolue-
ne, 1,2-dichloroethane and dichloromethane were 
tried for effective extraction of the colored ion pair 
complex from aqueous phase. Chloroform was found 
to be the most suitable solvent for extraction of co-
lored complex through double extraction with 5 mL 
each time, because of its higher efficiency on color 
intensity, selective extraction of the ion-pair complex 
from the aqueous phase, the highest absorbance ob-
tained and considerably lower extraction ability for the 
reagent blank and the shortest time to reach the equi-
librium between both chloroform and aqueous phases. 
Effect of time and temperature 
The optimum reaction time was investigated from 
0.5 to 4.0 min by following the color development at 
ambient temperature (25±2 °C). Complete color inten-
sity was attained after 2.0 min of mixing for all com-
plexes. Raising the temperature up to 30 °C had no 
effect on the absorbance of the formed complexes, 
whereas above 30 °C, the absorbance started to de-
cay. The absorbance remained stable for at least 48 h. 
Effects of pH on the ion-pair formation 
The effect of pH was studied by extracting the 
colored complexes in the presence of various buffers 
such as KCl-HCl (pH 1.5-4.2), NaOAc-HCl (pH 1.99- 
–4.92), NaOAc-AcOH (pH 2.8-6.0) and potassium hy-
drogen phthalate-HCl (pH 2.0-6.0). It was noticed that 
the maximum color intensity and highest absorbance 
value were observed in an acetate buffer of pH 3.5, 
which is the optimum pH value for buffers using BCP 
and MO, respectively. In addition, the stability of the 
color was enhanced without affecting the absorbance 
at the optimum pH values (Figure 2). Furthermore, 
2.0 mL of acetate buffer gave maximum absorbances 
and reproducible results. 
Effects of reagents concentration 
The effects of the reagents were studied by 
measuring the absorbance of solutions containing a 
fixed concentration of TDF (10 µg mL
-1) and varied 
amounts of the respective reagent. Maximum color in-
tensity of the complex was achieved with 2.0 or 1.5 ml 
of 0.1 % (w/v) (BCP and MO) reagent solutions, res-
pectively. A larger volume of the reagent had no pro-
nounced effect on the absorbance of the formed ion-
pair complex (Figure 3). 
Effect of sequence of mixing 
The most favorable sequence was (drug-rea-
gent–buffer-solvent) for the highest color intensity and 
the shortest time for developing maximum absorban-
ce, while the other sequences required longer time 
and produced lower absorbance values. 
Stoichiometric relationship 
Job’s method of continuous variation [22] of 
equimolar solutions was employed: a 5×10
-4 M stan-
dard solution of drug base and 5×10
-4 M solution of 
BCP and MO, respectively, were used. A series of so-
lutions was prepared in which the total volume of drug 
and reagent was kept at 10 mL for BCP and MO, res-
pectively. The absorbance was measured at the opti-
mum wavelength. The molar ratio of the reagents 
(drug:dye) in the ion-pair complexes was determined 
by the continuous variations method (Job’s method) 
 
Figure 2. Effect of pH of acetate buffer solution on the ion-pair complexes of TDF with dyes. A. AL KAF, A.A. GOUDA: SPECTROPHOTOMETRIC DETERMINATION OF TADALAFIL…  CI&CEQ 17 (2) 125−132 (2011) 
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(Figure 4). The results indicate that 1:1 (drug:dye) 
ion-pairs are formed through the electrostatic attrac-
tion between positive protonated TDF
+ and negative 
BCP
− and MO
-. The extraction equilibrium can be re-
presented as follows:  
TDF
+ + D
- (aq)  TDF
+ D
- (aq)  TDF
+ D
- (org) 
where TDF
+ and
 D
− represent the protonated TDF and 
the anion of the dye, respectively, and the subcript 
(aq) and (org) refer to the aqueous and organic pha-
ses, respectively. 
The stabilities of the ion-pair complexes were 
evaluated. The formation of the ion-pairs was rapid 
and the yellow color extracts were stable 48  h for 
drug-dye without any change in color intensity and the 
maximum absorbance at room temperature. 
 
Method validation 
Linearity 
At described experimental conditions for TDF 
determination, standard calibration curves for TDF 
with BCP and MO calibrations were constructed by 
plotting absorbance vs. concentration. The statistical 
parameters were given in the regression equation cal-
culated from the calibration graphs. The proposed 
methods were validated as per the ICH guidelines 
[23-25]. The linearity of calibration graphs was proved 
by the high values of the correlation coefficient (r) and 
the small values of the y-intercepts of the regression 
equations. The apparent molar absorptivities (ε) were 
calculated and found to be 1.332×10
4 and 1.033×10
4 
L mol
-1 cm
-1 for BCP and MO ion-pair complexes, res-
pectively, indicating a higher sensitivity of BCP than 
MO reagent. 
 
Figure 3. Effect of volume of 0.1 (w/v) of BCP and MO reagent concentration on the reaction of (10 µg mL
-1) TDF with dye. 
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Figure 4. Job’s method of continuous variation graph for the reaction of TDF with dyes BCP and MO, [drug]=[dye]= 5 x 10
-4 M. A. AL KAF, A.A. GOUDA: SPECTROPHOTOMETRIC DETERMINATION OF TADALAFIL…  CI&CEQ 17 (2) 125−132 (2011) 
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Relative standard deviations of response factors 
for each proposed spectrophotometric method were 
also calculated and recorded in Table 1. 
Sensitivity 
The detection limit (LOD) for the proposed me-
thods was calculated using the following Eq. [26]: 
LOD = 3s/k 
where s is the standard deviation of replicate deter-
mination values under the same conditions as for the 
sample analysis in the absence of the analyte and k is 
the sensitivity, namely the slope of the calibration 
graph. In accordance with the formula, the detection 
limits were found to be 0.092 and 0.11  μg mL
−1 for 
BCP and MO methods, respectively.  
The limits of quantization, LOQ, is defined as 
[26]; 
LOQ = 10s/k 
According to this equation, the limit of quan-
tization was found to be 0.31 and 0.37 μg mL
−1 for 
BCP and MO methods, respectively. 
Accuracy and precision 
Percentage relative standard deviation (RSD / %) 
as precision and percentage relative error (Er / %) as 
accuracy of the suggested method were calculated. 
Precision was carried out by six determinations at 
four different concentrations in these spectrophoto-
metric methods. The percentage relative error was 
calculated using the following equation: 
Er = ((Found – Added)/Added)×100 
The inter-day and intra-day precision and accu-
racy results are shown in Table 2. These results of 
accuracy and precision show that the proposed me-
thods have good repeatability and reproducibility. 
Effects of interference 
To assess the usefulness of the method, the ef-
fects of diluents, excipients and additives which often 
accompany TDF in its dosage forms (hydroxypropyl 
cellulose, hypromellose, iron oxide, lactose monohyd-
rate, magnesium stearate, microcrystalline cellulose, 
sodium lauryl sulfate, talc, titanium dioxide, and tri-
acetin) were studied. The results indicated that there 
is no interference from the degradation, indicating a 
high selectivity for determining the studied TDF in its 
dosage forms. 
Analysis of pharmaceutical preparations 
The suggested methods were applied success-
fully to the determination of TDF in commercial tablet. 
Six replicate determinations were made. Table 3 shows 
that satisfactory recovery data were obtained and the 
assay results were in good agreement with the label 
claims. Moreover, to check the validity of the pro-
posed methods, dosage forms were tested for possib-
le interference with standard addition method. There was 
Table 1. Statistical analysis of calibration graphs and analytical data in the determination of the studied drug using the proposed me-
thods (n = 6) 
Parameter 
Proposed method  
BCP MO 
Wavelength, λmax / nm  410  425 
Beer’s law limits, µg mL
−1 2.0-16  2.0-20 
Ringbom optimum range, µg mL
−1 3.0-14  4.0-18  
Molar absorptivity, ε / 10
–4 L mol
-1 cm
-1  1.332   1.033  
Sandell,s sensitivity, ng cm
-2 29.23  37.70 
Linear regression equation
a 
Intercept (a)  0.016   0.011 
Slope (b)  0.030 0.023 
Correlation coefficient (r) 0.9994  0.9992 
Limit of detection, LOD / μg mL
−1 0.092  0.11 
Limit of quantification, LOQ / μg mL
−1 0.31  0.37 
RSD / %  1.37 1.29 
RE / %  1.44 1.35 
t-Test
b  0.29 0.92 
F-Test
b  1.45 2.25 
a
A = a + bc, where c is the concentration in μg mL
−1, y is the absorbance units; 
b
the theoretical values of t and F at P = 0.05 are 2.571 and 6.39, respectivelyA. AL KAF, A.A. GOUDA: SPECTROPHOTOMETRIC DETERMINATION OF TADALAFIL…  CI&CEQ 17 (2) 125−132 (2011) 
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no significant difference between slopes of calibration 
curves and standard addition methods at two me-
thods. Therefore, it is concluded that the excipients in 
dosage forms of TDF such as starch, lactose, talc, 
stearic acid, titan dioxide, yellow iron oxide were not 
found to have any interference in the analysis of TDF. 
At 95% confidence level the calculated F-value did 
not exceed the theoretical F-value indicating no sig-
nificant difference between the two proposed me-
thods and the reported method [10] (Table 4). 
CONCLUSION 
Spectrophotometric analysis is of major interest 
in analytical pharmacy since it offers distinct possi-
bility in the assay of a particular component in dosage 
formulations. In the present study, the maximum color 
development of TDF with BCP or MO ion-pair com-
plex was instantaneous. No heating or standing was 
needed. These methods do not involve procedural 
steps and do not take more operator time and exper-
Table 2. Intra-day and inter-day precision and accuracy data for TDF obtained by the proposed methods (mean of five determination; 
RSD: percentage relative standard deviation; Er: percentage relative error) 
Method Added  concentration,  μg mL
-1 Recovery,  %  Precision,  RSD
a / %  Accuracy, Er / %  Confidence limit
a 
Intra-day 
BCP 4.0  100.03  0.84  0.03  4.001±0.0353 
8.0 99.79  0.92  -0.21  7.983±0.0771 
12 99.92  0.77  -0.08  11.990±0.0969 
16 100.05  1.08  0.05  16.008±0.1814 
MO 4.0  100.18  1.16  0.18  4.007±0.0488 
8.0 99.90  0.89  -0.10  7.992±0.0746 
12 99.86  0.79  -0.14  11.983±0.0164 
16 99.94  0.52  -0.06  15.990±0.0873 
Inter-day 
BCP 4.0  100.15  0.46  0.15  4.006±0.0189 
8.0 100.02  0.83  0.02  8.002±0.0697 
12 99.69  0.64  -0.31  11.963±0.0803 
16 99.75  0.91  -0.25  15.960±0.1524 
MO 4.0  99.65  1.07  -0.35  3.986±0.0448 
8.0 100.20  0.70  0.20  8.016±0.0589 
12 99.85  0.36  -0.15  11.982±0.0453 
16 100.20  0.30  0.20  16.032±0.0505 
a
Confidence limit at 95% confidence level and five degrees of freedom (t  = 2.776) 
Table 3. Determination of the studied drugs in their pharmaceutical dosage forms applying the standard addition technique (recovery±
± RSD, %; average of six determinations) 
Sample Taken,  μg mL
−1 Added,  μg mL
−1 
Proposed method
 
BCP MO 
Salil tablets  
(10 mg TDF/ tablet) 
4.0 2.0  99.94±0.43  99.74±0.51 
 6.0  99.85±0.67  99.66±0.62 
 8.0  100.07±0.45  99.95±0.38 
 12  100.05±0.64  99.80±0.71 
 
Table 4. Determination of the studied drugs in pharmaceutical dosage forms (recovery ± RSD, %; average of six determinations) 
Sample  Reported method [10] (n = 5) 
Proposed method
 
BCP MO 
Salil tablets 
(10 mg TDF/ tablet) 
100.30±0.74 99.98±0.55  99.79±0.56 
t
a = 1.76  t = 1.23 
F
a = 1.81  F = 1.75 
a
The theoretical values of t and F at P = 0.05 are 2.31 and 6.39, respectively A. AL KAF, A.A. GOUDA: SPECTROPHOTOMETRIC DETERMINATION OF TADALAFIL…  CI&CEQ 17 (2) 125−132 (2011) 
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tise like HPLC and other methods. In terms of simpli-
city, rapidity, sensitivity, expense and free from inter-
ference by common additives and excipients, the me-
thods could be considered superior in comparison 
with the previously reported methods, especially with 
those based on chromatography [3-7] or other re-
ported spectrophotometric methods [9-11]. The rea-
gents utilized in the proposed methods are cheaper, 
readily available and the procedures do not involve 
any critical reaction conditions or tedious sample pre-
paration. The method is unaffected by slight varia-
tions in experimental conditions such as time, reagent 
concentration or temperature. The proposed methods 
gave results with good accuracy to permit determi-
nation of low concentrations. The wide applicability of 
the described procedure for routine quality control is 
well established by the assay of TDF in pure form, as 
well as in tablets dosage forms. 
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NAUČNI RAD 
   SPEKTROFOTOMETRIJSKO ODREĐIVANJE 
TADALAFILA U ČISTOM STANJU I TABLETAMA 
Razvijene su dve brze i jednostavne spektrofotometrijske metode za određivanje tadala-
fila (TDF) i u čistom stanju i u tabletama. Metode se zasnivaju na ekstrakciji jonskih kom-
pleksa koji se formiraju u reakciji baznog azota TDF sa bromkrezol plavim (BCP) i metil-
-oranžom (MO) u kiselom puferovanom rastvoru. Ekstrakcija je vršena hloroformom, a 
apsorbanca je merena na 410 nm, odnosno 425 nm za reakciju sa BCP, odnosno za re-
akciju sa MO. Dokazano je da Berov zakon važi u opsegu koncentracije 2,0-20 µg mL
−1 
sa korelacionim koeficijentom (n = 6) ≥ 0.9996. Izračunata je molarna apsorptivnost i 
Sandelova osetljivost. Job-ovom metodom je određeno da je sastav jonskog kompleksa 
1:1. Predložene metode su uspešno primenjene za analizu TDF u čistom stanju i u ta-
bletama. Ove metode su validirane. Ispitani su tačnost, preciznost, limit detekcije i limit 
kvantifikacije. 
Ključne reči: tadalafil; spektrofotometrija; jonski kompleks; bromocrezol plavo; metil 
oranž. 
 
 